Pacific Global Investment Management’s Emergent Biosolutions EBS Stock Holding History

Pacific Global Investment Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,508	Closed	-$239K	–	222
2021 Q4	$239K	Sell	5,508 -4,453	-45%	-$201K	0.04%	200
2021 Q3	$499K	Sell	9,961 -391	-4%	-$23.7K	0.1%	136
2021 Q2	$652K	Sell	10,352 -210	-2%	-$13.5K	0.13%	123
2021 Q1	$981K	Sell	10,562 -454	-4%	-$46.5K	0.2%	97
2020 Q4	$987K	Sell	11,016 -196	-2%	-$18K	0.22%	99
2020 Q3	$1.16M	Sell	11,212 -79	-0.7%	-$8.52K	0.3%	76
2020 Q2	$893K	Sell	11,291 -7,349	-39%	-$548K	0.25%	90
2020 Q1	$1.08M	Buy	18,640 +9,232	+98%	+$532K	0.34%	76
2019 Q4	$508K	Buy	9,408 +2,523	+37%	+$137K	0.11%	144
2019 Q3	$360K	Buy	+6,885	New	+$321K	0.08%	159

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Pacific Global Investment Management's EBS Position: Q1 2022 in Review

Pacific Global Investment Management sold out of Emergent Biosolutions (EBS) in Q1 2022, closing a stake of 5,508 shares — an estimated $239K sold.

Pacific Global Investment Management first reported a position in EBS in Q3 2019 and held it in 10 quarters. The position peaked at $1.16M in Q3 2020. 255 funds tracked by Wall St. Rank hold EBS as of Q1 2022.

Pacific Global Investment Management reported no remaining Emergent Biosolutions position as of Q1 2022 after selling out during the quarter.
Pacific Global Investment Management sold 5,508 Emergent Biosolutions shares in Q1 2022, an estimated $239K.
Pacific Global Investment Management first reported a position in Emergent Biosolutions in Q3 2019 and held it in 10 quarters.
Pacific Global Investment Management's Emergent Biosolutions position peaked at $1.16M in Q3 2020.
255 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2022.

Based on Pacific Global Investment Management's 13F filing for Q1 2022, filed 25 Apr 2022.